AI & Tech··1 sources verified
Boltz Raises $110M Series A to Build AI Models for Small Molecule Research
Summarised by Relevant News AI · Read time: 3 min
Boltz PBC, a startup building AI models for pharmaceutical researchers, raised $110 million in a Series A round led by Bessemer. Greycroft, Andreessen Horowitz, Amplify Partners, F-Prime Capital, and Hummingbird also participated, along with other new and returning backers. The company says the funding will accelerate its work on small molecule research.
Why it matters: Large rounds for AI drug discovery startups signal where investors expect scientific AI tools to win, which matters to anyone building or buying models for life sciences.
All sources